Information Journal Paper
APA:
Copy. (2017). Safety, tolerability, and pharmacokinetics of liposomal amphotericin B in immunocompromised pediatric patients. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61(2), 0-0. SID. https://sid.ir/paper/721794/en
Vancouver:
Copy. Safety, tolerability, and pharmacokinetics of liposomal amphotericin B in immunocompromised pediatric patients. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY[Internet]. 2017;61(2):0-0. Available from: https://sid.ir/paper/721794/en
IEEE:
Copy, “Safety, tolerability, and pharmacokinetics of liposomal amphotericin B in immunocompromised pediatric patients,” ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 61, no. 2, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/721794/en